Literature DB >> 12684765

Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.

Moriz Buzello1, Christoph Boehm, Stephan Orth, Bernhard Fischer, Heimo Ehmke, Eberhard Ritz, Gerhard Mall, Kerstin Amann.   

Abstract

Left ventricular hypertrophy (LVH) develops very early in experimental renovascular hypertension after clipping of one renal artery and is accompanied by a remodeling of cardiac structure which has not yet been investigated in detail. It was the aim of the present study to analyze changes in cardiomyocyte number and volume in LVH after 2 weeks of renovascular hypertension. Sprague-Dawley rats were subjected to clipping of the left renal artery (2K1C) or sham operation (sham). One group of 2K1C rats received antihypertensive treatment with dihydralazine. The experiment was terminated after 2 weeks. Hearts were investigated using stereological methods, electron microscopy, immunohistology for the proliferation marker proliferating cell nuclear antigen, the pro- and anti-apoptotic proteins Bax and Bcl-2 as well as the TUNEL technique. After 2 weeks, systolic blood pressure and relative left ventricular weight were significantly higher in untreated 2K1C animals than in sham and dihydralazine-treated 2K1C rats. Volume fraction of interstitial tissue and capillary length density were not different, whereas wall thickness of intramyocardial arteries was significantly higher in untreated 2K1C (5.12+/-0.7 micro m) than in sham (3.92+/-0.6 micro m) and in dihydralazine-treated 2K1C (3.91+/-0.7 micro m) rats. Cardiomyocyte diameter and volume were significantly higher in untreated 2K1C than in sham animals. The number of cardiomyocytes per left ventricle was significantly lower in untreated 2K1C rats (5.5+/-1.6 vs 3.9+/-6.9 x10(7)). Using immunohistochemistry, no direct evidence of apoptosis was found, but a relative higher expression of the anti-apoptotic protein bcl-2 expression was seen in untreated 2K1C than in sham animals. This may reflect a protective mechanism as a consequence of earlier occurring apoptosis. These observations document that experimental renovascular hypertension induces a rapidly developing LVH characterized by marked cardiac remodeling and substantial loss of cadiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684765     DOI: 10.1007/s00428-003-0775-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

1.  Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.

Authors:  P Moreau; L V d'Uscio; S Shaw; H Takase; M Barton; T F Lüscher
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

2.  Endothelin system-dependent cardiac remodeling in renovascular hypertension.

Authors:  B Hocher; I George; J Rebstock; A Bauch; A Schwarz; H H Neumayer; C Bauer
Journal:  Hypertension       Date:  1999-03       Impact factor: 10.190

3.  Apoptosis in pressure overload-induced heart hypertrophy in the rat.

Authors:  E Teiger; V D Than; L Richard; C Wisnewsky; B S Tea; L Gaboury; J Tremblay; K Schwartz; P Hamet
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.

Authors:  P E Massart; J Donckier; J Kyselovic; T Godfraind; G R Heyndrickx; M Wibo
Journal:  Hypertension       Date:  1999-12       Impact factor: 10.190

5.  Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats.

Authors:  S Guan; J Fox; K D Mitchell; L G Navar
Journal:  Hypertension       Date:  1992-12       Impact factor: 10.190

6.  Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats.

Authors:  S Kim; K Ohta; A Hamaguchi; T Yukimura; K Miura; H Iwao
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

7.  Absolute morphometric study of myocardial hypertrophy in experimental hypertension. I. Determination of myocyte size.

Authors:  A V Loud; P Anversa; F Giacomelli; J Wiener
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

8.  Absolute morphometric study of myocardial hypertrophy in experimental hypertension. II. Ultrastructure of myocytes and interstitium.

Authors:  P Anversa; A V Loud; F Giacomelli; J Wiener
Journal:  Lab Invest       Date:  1978-05       Impact factor: 5.662

Review 9.  Renal nerves in the pathogenesis of hypertension in experimental animals and humans.

Authors:  R E Katholi
Journal:  Am J Physiol       Date:  1983-07

10.  Reaction patterns of the myocardial interstitium in different models of cardiac hypertrophy--stereological investigations.

Authors:  G Mall; T Mattfeldt; M Rambausek; C Hasslacher; J Mann; E Ritz
Journal:  Gegenbaurs Morphol Jahrb       Date:  1989
View more
  8 in total

1.  Differences in left ventricular cardiomyocyte loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  Tsung-I Chen; Ching-Jung Lai; Chien-Ju Hsieh; Ke-Li Tsai; Kun-Ta Yang
Journal:  Sleep Breath       Date:  2010-12-07       Impact factor: 2.816

2.  Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.

Authors:  Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

3.  ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.

Authors:  M-L Gross; N Heiss; M Weckbach; A Hansen; A El-Shakmak; A Szabo; K Münter; E Ritz; K Amann
Journal:  Diabetologia       Date:  2004-01-15       Impact factor: 10.122

4.  Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats.

Authors:  Leonardo de Souza Mendonça; Caroline Fernandes-Santos; Carlos Alberto Mandarim-de-Lacerda
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

Review 5.  Cardiac resynchronization therapy in CKD: a systematic review.

Authors:  Neha Garg; George Thomas; Gregory Jackson; John Rickard; Joseph V Nally; W H Wilson Tang; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

6.  Urocortin 2 Gene Transfer Improves Heart Function in Aged Mice.

Authors:  Dimosthenis Giamouridis; Mei Hua Gao; N Chin Lai; Tracy Guo; Atsushi Miyanohara; W Matthijs Blankesteijn; Erik A L Biessen; H Kirk Hammond
Journal:  Mol Ther       Date:  2019-10-29       Impact factor: 11.454

7.  Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.

Authors:  Maria Hennig; Saskia Fiedler; Christian Jux; Ludwig Thierfelder; Jörg-Detlef Drenckhahn
Journal:  J Am Heart Assoc       Date:  2017-08-04       Impact factor: 5.501

8.  Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension.

Authors:  Ali Akbar Nekooeian; Amin Rasti Pour; Farzaneh Dehghani; Elaheh Mashghoolozekr; Tahereh Esmaeilpour
Journal:  Iran J Med Sci       Date:  2021-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.